{
  "slug": "bioages-bge-102-achieve-primary-endpoint-phase-2-quell-cv-trial-before-january",
  "canonical_title": "Will BioAge's BGE-102 achieve its primary endpoint in the Phase 2 QUELL-CV trial before January 1, 2028?",
  "category": "other",
  "consensus_probability": 0.5163,
  "total_volume_usd": 0,
  "platform_count": 1,
  "market_count": 1,
  "spread_pp": 0,
  "last_updated_at": "2026-08-06T06:12:04.843Z",
  "markets": [
    {
      "platform": "manifold",
      "probability_yes": 0.5163463975091757,
      "volume_usd": null,
      "source_url": "https://manifold.markets/trialz/will-bioages-bge102-achieve-its-pri",
      "fetched_at": "2026-08-06T06:12:04.843Z"
    }
  ],
  "history": [
    {
      "snapshot_at": "2026-08-06T04:07:04.840Z",
      "probability_yes": 0.46999999999999975
    },
    {
      "snapshot_at": "2026-08-06T04:18:04.842Z",
      "probability_yes": 0.5163463975091757
    }
  ],
  "license": "CC-BY-4.0",
  "source": "https://beeks.ai"
}